All articles by Lara Williams
Lara Williams
Lara Williams is managing editor of Verdict technology. An experienced writer, Lara previously worked as deputy editor of the Financial Times’s fDi Magazine. Lara has a background in technology journalism writing for the UK’s Computing magazine and has spent almost a decade living in Silicon Valley.
Women in tech: a three-pronged approach to gender inclusivity
Shalini Khemka, CBE, shares her three strategies for greater gender inclusion within the technology industry.
Can the UK’s Online Safety Bill ensure online safety for minors?
Dr Heinrich Grave, senior vice president for digital identity verification platform, IDnow, outlines why protecting minors online is proving so difficult.
Salesforce announces SlackGPT
Salesforce owned messaging app, Slack, is the latest company to integrate generative AI into its core business.
Google AI pioneer joins chorus of concern over potential AI threat
Google continues to invest heavily in AI including its generative AI product, Bard, despite widespread concerns over potential AI threats.
Wikipedia becomes latest critic of UK’s online safety bill
The UK’s proposed Online Safety Bill requires age checks which Wikipedia says it cannot enforce for privacy reasons.
Social media’s top ten ‘finfluencers’ revealed
A new study reveals the top ten influencers in the field of finance – all of whom have amassed significant social media followings.
Microsoft unbundles Teams to avoid EU antitrust scrutiny
US big tech companies face increasing regulatory pressure for anti-competitive practices, both at home and overseas.
Apple launches Goldman Sachs savings account
Apple is following a trend for Big Tech companies integrating financial services products into their core business.
Europe passes landmark crypto regulation
The European Parliament’s passing of the Markets in Crypto-Assets act will establish the continent as a global centre of gravity for the crypto economy.
Covid fighting tech outpaces other virus patent filings
The Covid-19 crisis saw an innovation boost in vaccine and therapeutics which has resulted in an increase in Covid-related patents.